Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Talcum Powder Injury Lawyers Oppose J&J’s Attempt To Further Delay Litigation By Rearguing Expert Challenges Plaintiffs say Johnson & Johnson wants to relitigate Daubert challenges that were decided by the Court two years ago, in yet another attempt to prevent individuals dying of cancer from receiving compensation. August 25, 2023 Irvin Jackson Add Your Comments Following two failed bankruptcy attempts and a nearly two year stay on all progress in thousands of talcum powder lawsuits being pursued by women diagnosed with ovarian cancer, plaintiff’s lawyers are urging the U.S. District Judge recently appointed to preside over the litigation to reject yet another delay tactic by Johnson & Johnson, which seeks to reargue expert witness challenges that were already decided by the previous judge assigned to the cases. Johnson & Johnson faces more than 60,000 Baby powder lawsuits and Shower-to-Shower lawsuits filed throughout the federal court system, each involving similar allegations that asbestos particles in the talc-based products caused users to develop ovarian cancer, mesothelioma, and other injuries. Following massive jury awards returned in cases that went to trial several years ago, the manufacturer decided to initiate a controversial talcum powder bankruptcy scheme in 2021, as part of an attempt to force any settlement for the cases through the U.S. bankruptcy system. Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Talcum Powder Lawsuits Talcum powder or talc powder may cause women to develop ovarian cancer. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Until this month, plaintiffs have been barred from filing new talcum powder claims under a bankruptcy stay, and additional bellwether trials expected to begin nearly two years ago have been on hold while challenges were filed to the bankruptcy. Although Johnson & Johnson has billions of assets on hand, the company attempted a maneuver known as the “Texas Two Step” in 2021, by transferring all liability it faced in the litigation to a new subsidiary, LTL Management, LLC, which then immediately filed for bankruptcy protection. Following several years of challenges to the filing, the Third Circuit Court of Appeals ultimately rejected that initial bankruptcy filing in March 2023, finding that LTL Management faced no real financial distress. Just as the litigation was set to get underway once again earlier this year, Johnson & Johnson immediately initiated a second bankruptcy filing, as part of a proposed $8.9 billion talcum powder settlement fund that it hoped to use to force all current and future plaintiffs to resolve their claims through the U.S. bankruptcy system. However, plaintiffs objected to the move, claiming it would force individuals diagnosed with cancer to accept minimal offers for their claims, and prevent all future individuals injured by talcum powder from pursuing a lawsuit through the civil court system. Last month, U.S. Bankruptcy Judge Michael B. Kaplan rejected the second talcum powder bankruptcy, after determining that it was “filed in bad faith” and that LTL Management still did not face financial distress requiring bankruptcy protections. Therefore, active litigation is set to get underway again in a federal talcum powder MDL, which was initially established in 2016. The litigation was initially assigned to U.S. District Judge Freda Wolfson, who announced her retirement earlier this year. Therefore, Judge Michael Shipp was appointed to preside over further management of the talcum powder lawsuits. Talcum Powder Injury Lawyers Push Back Against Further Delays In recent court filings, plaintiffs’ attorneys have noted that many individuals who have filed talcum powder lawsuits face life-threatening cancer diagnoses, and some have died while waiting for their day in court due to Johnson & Johnson’s rejected delaying tactics. They are now trying to prevent further delays by pushing back against what they say are plans for Johnson & Johnson to again challenge expert witness testimony, despite Judge Wolfson previously ruling on those challenges years ago. Their objections to Johnson & Johnson’s plans to reargue Daubert motions were outlined in a letter (PDF) to the court issued on August 23. “After delaying this MDL litigation for nearly two years via multiple failed bankruptcy efforts, Defendants seek to further delay bellwether trials by redoing that which has already been done in this case,” talcum powder injury lawyers wrote. “Although it is acceptable for the court to ‘at least a limited review of the expert’s conclusions ‘in order to determine whether they could reliably flow from the facts known to the expert and the methodology used,’ neither the passage of time nor the publication of new literature undermines the sound methodologies employed or conclusions reached by Plaintiffs’ experts.” Plaintiffs filed a proposed scheduling order along with the letter, which details how they will respond to requests to produce records for discovery over the next several months, if the Court refuses Johnson & Johnson’s request to reargue expert witness challenges. Plaintiffs Push For No Further Delays in Talcum Powder Lawsuits Prior to the initial talcum powder lawsuit bankruptcy stay, the parties were planning for a series of early bellwether trials to be held, to help gauge how juries are likely to respond to certain evidence and testimony that is likely to be repeated throughout the litigation. To make up for lost time, plaintiffs are now pushing the court to quickly resume trial prep. In August, plaintiffs sent another letter to Judge Shipp, calling for the Court to begin moving the cases toward trial “expeditiously.” In response, Judge Shipp issued a docket order scheduling a status conference for September 6. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior legal and investigative journalist with more than 30 years of experience covering complex issues at the intersection of law, politics, and environmental policy. He began his reporting career in 1991 after graduating from Wayne. Tags: Asbestos, Baby Powder, Bankruptcy, Cancer, Johnson & Johnson, Ovarian Cancer, Shower to Shower, Talcum Powder More Talcum Powder Lawsuit Stories Lawyers Ordered To Engage in Talcum Powder Settlement Talks in MDL July 3, 2025 Talcum Powder Ovarian Cancer Lawsuit Selected for First Federal Bellwether Trial July 1, 2025 Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions June 20, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: yesterday) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025) Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial (Posted: 2 days ago) A federal judge has issued a rare remand to send a Roundup non-Hodgkin’s lymphoma lawsuit to trial, noting that most claims have settled before getting that far. MORE ABOUT: ROUNDUP LAWSUITSNew Study Appears To Confirm Link Between Roundup and Cancer (07/07/2025)U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits (07/01/2025)Roundup Lawsuit Payout of $611M Upheld by Appeals Court (05/29/2025) Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims (Posted: 2 days ago) A federal judge has issued a census order to gain an accurate count of all Similac NEC lawsuits filed against Abbott Laboratories. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court (07/08/2025)NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 (06/23/2025)Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (06/17/2025)
Depo-Provera MDL Judge Pushes for Meningioma Lawsuits To Be Filed Quicker (Posted: yesterday) A federal judge has ordered plaintiffs’ attorneys involved in Depo-Provera meningioma lawsuits to reveal how many claims remain unfiled. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Diagnosis Resulted in Invasive Brain Surgery, Lawsuit Alleges (07/21/2025)Over 550 Depo-Provera Lawsuits Being Pursued by Women With Meningioma Brain Tumors (07/15/2025)Depo-Provera Shots Triple Brain Tumor Risks Compared to Birth Control Pill: Study (07/11/2025)
Roundup Non-Hodgkin’s Lymphoma Lawsuit Remanded From MDL for Trial (Posted: 2 days ago) A federal judge has issued a rare remand to send a Roundup non-Hodgkin’s lymphoma lawsuit to trial, noting that most claims have settled before getting that far. MORE ABOUT: ROUNDUP LAWSUITSNew Study Appears To Confirm Link Between Roundup and Cancer (07/07/2025)U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits (07/01/2025)Roundup Lawsuit Payout of $611M Upheld by Appeals Court (05/29/2025)
Similac NEC Settlement Talks Result in MDL Census Order for Filed and Unfiled Claims (Posted: 2 days ago) A federal judge has issued a census order to gain an accurate count of all Similac NEC lawsuits filed against Abbott Laboratories. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMead Johnson Must Face Enfamil NEC Lawsuit in Missouri State Court (07/08/2025)NEC Formula Lawsuit Set To Go Before Jury in Aug. 2025 (06/23/2025)Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (06/17/2025)